Clascoterone | ||||
CAS NO.: | 19608-29-8 | |||
Chemical Formula: | C24H34O5 | |||
Molecular Weight: | 402.5000 | |||
DMF&GMP status: | Please contact us for more details. | Description: |
Also named as 17 alpha-propionate.
Clascoterone API (19608-29-8) has been used in trials studying the treatment of Acne Vulgaris. It is also under development for the treatment of androgen-dependent scalp hair loss.[2] The medication is used as a cream by application to the skin, for instance the face and scalp. **The products protected by patents in this product catalog are used for laboratory analysis, research and development, and cannot be sold to any country or region with patent protection and for commercial purpose. If the resulting patent infringement risks and responsibilities will be borne by the buyer. |
|
Approvals | ||||
Active Ingredient | Dosage Form; Route | Strength | Proprietary Name | Applicant |
CLASCOTERONE | CREAM;TOPICAL | 1% | WINLEVI | CASSIOPEA SPA |
Patent Data | ||||
Patent No. | Patent Expiration | Drug Substance Claim | Drug Product Claim | Patent Use Code |
8143240 | 01/12/2023 | CLASCOTERONE | U-2942 | |
8785427 | 07/25/2030 | CLASCOTERONE | DP | |
8865690 | 07/24/2022 | CLASCOTERONE | U-2942 | |
9211295 | 07/24/2022 | CLASCOTERONE | DP | |
9433628 | 02/08/2029 | CLASCOTERONE | DP | |
9486458 | 07/24/2028 | CLASCOTERONE | U-2942 | |
10159682 | 08/14/2028 | CLASCOTERONE | U-2942 | |
Exclusive Data | ||||
Exclusivity Code | Exclusivity Expiration | |||
NCE | 08/26/2025 | |||